Sanger Sequencing Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The sanger sequencing market size has grown rapidly in recent years. It will grow from $2.75 billion in 2024 to $3.3 billion in 2025 at a compound annual growth rate (CAGR) of 19.8%. The growth in the historic period can be attributed to increased research demand, increasing medical diagnostics, increased pharmaceutical development, increased agricultural applications, increased forensic analysis, increased biomarker discovery, increased genetic evolution studies.

The sanger sequencing market size is expected to see rapid growth in the next few years. It will grow to $6.17 billion in 2029 at a compound annual growth rate (CAGR) of 16.9%. The growth in the forecast period can be attributed to increasing clinical genomics integration, expanded agricultural genomics, increasing drug safety and pharmacogenomics, increasing prenatal and newborn screening, increasing environmental DNA analysis. Major trends in the forecast period include technological advancements, growing demand for next-generation sequencing, increasing applications in clinical diagnostics, rising investments in genomics research, expanding use in personalized medicine.

The increase in genetic illnesses is expected to drive the growth of the Sanger sequencing market in the coming years. Genetic illnesses, or genetic disorders, are medical conditions caused by abnormalities or mutations in an individual's DNA, the hereditary material that carries genetic information. Sanger sequencing is a method used to diagnose these disorders by determining the precise order of nucleotides (the building blocks of DNA) in a specific gene or DNA region. For example, in August 2024, the National Health Service, a UK-based publicly funded healthcare organization, reported that around 2,300 people in the UK are living with thalassemia, with approximately 800 individuals affected by the severe form of the condition who rely on regular blood transfusions. Thus, the rise in genetic illnesses is fueling the growth of the Sanger sequencing market.

Leading companies in the Sanger sequencing market are focusing on expanding genomic laboratories to offer rapid Sanger sequencing services in the northern UK. Genomic laboratories are specialized facilities for conducting genetic testing and analysis, aimed at studying the structure, function, and inheritance of genes and genomes for purposes such as diagnosis, research, and personalized medicine. In June 2023, for instance, Source Genomics, a UK-based provider of genomic services, announced the expansion of their genomic laboratory to the north of the UK, which will increase their capacity for Sanger sequencing services and reduce data turnaround times. This geographic expansion represents a significant step in providing equitable access to genomic services across the UK, enabling research organizations nationwide to benefit from high-quality Sanger sequencing services with faster turnaround times.

In January 2023, Qiagen, a German company specializing in sample and assay technologies, acquired Verogen for $150 million. This strategic move enables Qiagen to optimize its renowned sample extraction and library preparation automation capabilities, thereby bolstering the channel reach and market presence of both companies in support of the forensic market. Verogen, based in the United States, is a leading provider of Sanger sequencing solutions tailored for human identification and forensic laboratories.

Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies.

North America was the largest region in the sanger sequencing market in 2024. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sanger sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sanger sequencing market includes revenues earned by entities by providing DNA synthesis, and targeted synthesis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Sanger sequencing, also known as chain termination sequencing, is a technique utilized to determine the nucleotide sequence of DNA. It finds application in smaller-scale projects and validating the results of deep sequencing, producing DNA sequence reads exceeding 500 nucleotides while maintaining high accuracy levels.

Sanger sequencing encompasses several types, including shotgun sequencing, targeted gene sequencing, and others. In shotgun sequencing, random fragments of a lengthy DNA molecule are sequenced in parallel and then pieced together using their overlapping segments. Laboratories employing Sanger sequencing methods can be categorized as wet labs or dry labs, while research endeavors can be conducted in-house or outsourced. These techniques are employed across various applications such as diagnostics, biomarkers, cancer research, reproductive health, personalized medicine, forensics, among others. Moreover, Sanger sequencing serves a diverse range of end-users including academic institutions, government research institutes, pharmaceutical companies, biotechnology firms, hospitals, and clinics.

The sanger sequencing market research report is one of a series of new reports that provides sanger sequencing market statistics, including sanger sequencing industry global market size, regional shares, competitors with a sanger sequencing market share, detailed sanger sequencing market segments, market trends, and opportunities, and any further data you may need to thrive in the sanger sequencing industry. This sanger sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.